Wright Lassiter III - 01 Apr 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role
Director
Signature
Sean D. Mersten, Attorney in Fact for Wright L. Lassiter, III
Issuer symbol
DGX
Transactions as of
01 Apr 2025
Net transactions value
$0
Form type
4
Filing time
03 Apr 2025, 16:40:32 UTC
Previous filing
31 Mar 2025
Next filing
19 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DGX Phantom Stock Units Award $0 +169 +89% $0.000000 360 01 Apr 2025 Common Stock 169 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.
F2 Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11.